Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCP Pretreatment in PCOS IVF/ICSI
NCT03881904Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Jun 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ethinyl estradiol + gestodene in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Ain Shams University. Primary endpoint: Ongoing pregnancy rate. Status: unknown.
02
Drugs
ethinyl estradiol + gestodene
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03881904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03881904.